Glen Baker - Publications

Neuroscience and Mental Health Institute University of Alberta, Edmonton, Alberta, Canada 

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Therapeutic Advances in Psychopharmacology. 10: 2045125320916657. PMID 32440333 DOI: 10.1177/2045125320916657  0.36
2019 Marinas JE, Matveychuk D, Dursun SM, Baker GB. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry. Acta Neuropsychiatrica. 1-27. PMID 31791436 DOI: 10.1017/neu.2019.50  0.36
2019 Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Chemico-Biological Interactions. PMID 30857888 DOI: 10.1016/j.cbi.2019.03.003  0.52
2019 MacKay MB, Kravtsenyuk M, Thomas R, Mitchell ND, Dursun SM, Baker GB. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression? Frontiers in Psychiatry. 10: 25. PMID 30787885 DOI: 10.3389/fpsyt.2019.00025  0.36
2018 MacKay MB, Paylor JW, Wong JTF, Winship IR, Baker GB, Dursun SM. Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics. Frontiers in Psychiatry. 9: 537. PMID 30425662 DOI: 10.3389/fpsyt.2018.00537  0.76
2018 Mifflin K, Baker GB, Kerr BJ. Effect of Voluntary Wheel Running on Neuroactive Steroid Levels in Murine Experimental Autoimmune Encephalomyelitis. Neuroscience Letters. PMID 30171909 DOI: 10.1016/j.neulet.2018.08.040  0.32
2018 Potter LE, Doolen S, Mifflin K, Tenorio G, Baker G, Taylor BK, Kerr BJ. Antinociceptive effects of the antidepressant phenelzine are mediated by context-dependent inhibition of neuronal responses in the dorsal horn. Neuroscience. PMID 29752984 DOI: 10.1016/j.neuroscience.2018.04.047  0.32
2018 Winship IR, Dursun SM, Baker GB, Balista PA, Kandratavicius L, Maia-de-Oliveira JP, Hallak J, Howland JG. An Overview of Animal Models Related to Schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718773728. PMID 29742910 DOI: 10.1177/0706743718773728  0.76
2018 Hamill J, Hallak J, Dursun SM, Baker G. Ayahuasca: Psychological And Physiologic Effects, Pharmacology And Potential Uses In Addiction And Mental Illness. Current Neuropharmacology. PMID 29366418 DOI: 10.2174/1570159X16666180125095902  0.36
2017 Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, Di Pardo A, Holt A, Kerr BJ, Todd KG, Baker GB, Fouad K, Sipione S. Disease-modifying effects of ganglioside GM1 in Huntington's disease models. Embo Molecular Medicine. PMID 28993428 DOI: 10.15252/emmm.201707763  0.52
2017 Mifflin KA, Frieser E, Benson C, Baker G, Kerr BJ. Voluntary wheel running differentially affects disease outcomes in male and female mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 305: 135-144. PMID 28284334 DOI: 10.1016/j.jneuroim.2017.02.005  0.32
2017 Riske L, Thomas RK, Baker GB, Dursun SM. Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorder. Therapeutic Advances in Psychopharmacology. 7: 85-89. PMID 28255438 DOI: 10.1177/2045125316675579  0.36
2016 Alles SR, Bandet MV, Eppler K, Noh MC, Winship IR, Baker G, Ballanyi K, Smith PA. Acute anti-allodynic action of gabapentin in dorsal horn and primary somatosensory cortex: Correlation of behavioural and physiological data. Neuropharmacology. PMID 27856391 DOI: 10.1016/j.neuropharm.2016.11.011  0.76
2016 Zheng HF, Wang WQ, Li XM, Rauw G, Baker GB. Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. Amino Acids. PMID 27686223 DOI: 10.1007/s00726-016-2332-y  0.52
2016 Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis. Journal of Neuroinflammation. 13: 142. PMID 27282914 DOI: 10.1186/s12974-016-0609-4  0.52
2015 Mifflin K, Benson C, Thorburn K, Baker GB, Kerr BJ. Manipulation of neurotransmitter levels has differential effects on formalin evoked nociceptive behaviour in male and female mice. The Journal of Pain : Official Journal of the American Pain Society. PMID 26748043 DOI: 10.1016/j.jpain.2015.12.013  0.52
2015 Benson C, Mifflin K, Kerr B, Jesudasan SJ, Dursun S, Baker G. Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression. Modern Trends in Pharmacopsychiatry. 30: 67-79. PMID 26437459 DOI: 10.1159/000435933  0.52
2015 Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S, Baker G. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Modern Trends in Pharmacopsychiatry. 30: 94-102. PMID 26436548 DOI: 10.1159/000435935  0.52
2015 Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26316187 DOI: 10.1093/ijnp/pyv078  0.52
2015 Benson C, Paylor JW, Tenorio G, Winship I, Baker G, Kerr BJ. Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE). Experimental Neurology. 271: 279-290. PMID 26033473 DOI: 10.1016/j.expneurol.2015.05.017  0.52
2015 Kandratavicius L, Balista PA, Wolf DC, Abrao J, Evora PR, Rodrigues AJ, Chaves C, Maia-de-Oliveira JP, Leite JP, Dursun SM, Baker GB, Guimaraes FS, Hallak JE. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. Bmc Neuroscience. 16: 9. PMID 25887360 DOI: 10.1186/s12868-015-0149-3  0.52
2015 Haile Y, Nakhaei-Nejad M, Boakye PA, Baker G, Smith PA, Murray AG, Giuliani F, Jahroudi N. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes. Plos One. 10: e0119617. PMID 25789622 DOI: 10.1371/journal.pone.0119617  0.52
2015 Maia-de-Oliveira JP, Lobão-Soares B, Ramalho T, Gavioli EC, Soares VP, Teixeira L, Baker GB, Dursun SM, Hallak JE. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week. Schizophrenia Research. 162: 211-5. PMID 25586741 DOI: 10.1016/j.schres.2014.12.035  0.52
2015 Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JA, Belmonte-de-Abreu P, Baker GB, Dursun SM, Hallak JE. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. Journal of Clinical Psychopharmacology. 35: 83-5. PMID 25502490 DOI: 10.1097/JCP.0000000000000258  0.52
2015 Chaves C, Marque CR, Maia-de-Oliveira JP, Wichert-Ana L, Ferrari TB, Santos AC, Araújo D, Machado-de-Sousa JP, Bressan RA, Elkis H, Crippa JA, Guimarães FS, Zuardi AW, Baker GB, Dursun SM, et al. Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia. Schizophrenia Research. 161: 439-45. PMID 25497439 DOI: 10.1016/j.schres.2014.11.031  0.52
2014 Maia-de-Oliveira JP, Lobão-Soares B, Baker GB, Dursun SM, Hallak JE. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems. Schizophrenia Research. 159: 558-9. PMID 25223842 DOI: 10.1016/j.schres.2014.08.020  0.52
2014 Maia-de-Oliveira JP, Belmonte-de-Abreu P, Bressan RA, Cachoeira C, Baker GB, Dursun SM, Hallak JE. Sodium nitroprusside treatment of clozapine-refractory schizophrenia. Journal of Clinical Psychopharmacology. 34: 761-3. PMID 25203464 DOI: 10.1097/JCP.0000000000000217  0.52
2014 Noorbakhsh F, Baker GB, Power C. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis. Frontiers in Cellular Neuroscience. 8: 134. PMID 24917787 DOI: 10.3389/fncel.2014.00134  0.52
2014 Matveychuk D, Nunes E, Ullah N, Aldawsari FS, Velázquez-Martínez CA, Baker GB. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 53: 67-73. PMID 24607770 DOI: 10.1016/j.pnpbp.2014.02.011  0.52
2014 Acharjee S, Branton WG, Vivithanaporn P, Maingat F, Paul AM, Dickie P, Baker GB, Power C. HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain, Behavior, and Immunity. 40: 74-84. PMID 24607605 DOI: 10.1016/j.bbi.2014.02.016  0.52
2014 Cherkasova MV, Faridi N, Casey KF, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Dagher A, Leyton M, Benkelfat C. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1498-507. PMID 24378745 DOI: 10.1038/npp.2013.349  0.52
2014 Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M. Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. Biological Psychiatry. 76: 23-30. PMID 24138922 DOI: 10.1016/j.biopsych.2013.08.033  0.52
2014 Li Y, Li L, Stephens MJ, Zenner D, Murray KC, Winship IR, Vavrek R, Baker GB, Fouad K, Bennett DJ. Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats. Journal of Neurophysiology. 111: 145-63. PMID 24068759 DOI: 10.1152/jn.00508.2013  0.52
2013 Nunes EA, Rezende TM, Morais SL, Crippa JA, Dursun SM, Baker GB, Hallak JE. Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Therapeutic Advances in Psychopharmacology. 3: 83-8. PMID 24167679 DOI: 10.1177/2045125312464995  0.36
2013 Casey KF, Cherkasova MV, Larcher K, Evans AC, Baker GB, Dagher A, Benkelfat C, Leyton M. Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 15285-94. PMID 24048857 DOI: 10.1523/JNEUROSCI.5029-12.2013  0.52
2013 Chue PS, Baker GB. Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia? Future Medicinal Chemistry. 5: 1475-7. PMID 24024940 DOI: 10.4155/fmc.13.118  0.52
2013 Benson CA, Wong G, Tenorio G, Baker GB, Kerr BJ. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE). Behavioural Brain Research. 252: 302-11. PMID 23777648 DOI: 10.1016/j.bbr.2013.06.019  0.52
2013 Hallak JE, Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JA, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. Jama Psychiatry. 70: 668-76. PMID 23699763 DOI: 10.1001/jamapsychiatry.2013.1292  0.52
2013 Song MS, Matveychuk D, MacKenzie EM, Duchcherer M, Mousseau DD, Baker GB. An update on amine oxidase inhibitors: multifaceted drugs. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 118-24. PMID 23410524 DOI: 10.1016/j.pnpbp.2013.02.001  0.52
2013 Matveychuk D, Nunes E, Ullah N, Velázquez-Martinez CA, MacKenzie EM, Baker GB. Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 987-96. PMID 23392617 DOI: 10.1007/s00702-013-0978-0  0.52
2013 Maingat FG, Polyak MJ, Paul AM, Vivithanaporn P, Noorbakhsh F, Ahboucha S, Baker GB, Pearson K, Power C. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 725-37. PMID 23150523 DOI: 10.1096/fj.12-215079  0.52
2013 Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. Journal of Psychiatry & Neuroscience : Jpn. 38: 6-23. PMID 22894822 DOI: 10.1503/jpn.110190  0.52
2012 Maia-de-Oliveira JP, Trzesniak C, Oliveira IR, Kempton MJ, Rezende TM, Iego S, Baker GB, Dursun SM, Machado-de-Sousa JP, Hallak JE. Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 34: S149-55. PMID 23429845 DOI: 10.1016/j.rbp.2012.07.001  0.52
2012 Nunes EA, Canever L, Oliveira Ld, Luca RD, Quevedo J, Zugno A, Peregrino A, Crippa JA, Dursun SM, Baker GB, Hallak JE. Effects of pregabalin on behavioral alterations induced by ketamine in rats. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 34: 329-33. PMID 23429779 DOI: 10.1016/j.rbp.2012.02.005  0.52
2012 Chue PS, MacKenzie EM, Chue JA, Baker GB. The pharmacology and formulation of paliperidone extended release. Expert Review of Neurotherapeutics. 12: 1399-410. PMID 23237347 DOI: 10.1586/ern.12.138  0.52
2012 Mousseau DD, Baker GB. Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function? Current Topics in Medicinal Chemistry. 12: 2163-76. PMID 23231394  0.52
2012 Al-Nuaimi SK, Mackenzie EM, Baker GB. Monoamine oxidase inhibitors and neuroprotection: a review. American Journal of Therapeutics. 19: 436-48. PMID 22960850 DOI: 10.1097/MJT.0b013e31825b9eb5  0.52
2012 Nunes EA, Freire RC, Dos Reis M, de Oliveira E Silva AC, Machado S, Crippa JA, Dursun SM, Baker GB, Hallak JE, Nardi AE. Sulpiride and refractory panic disorder. Psychopharmacology. 223: 247-9. PMID 22864966 DOI: 10.1007/s00213-012-2818-6  0.52
2012 Nunes EA, MacKenzie EM, Rossolatos D, Perez-Parada J, Baker GB, Dursun SM. D-serine and schizophrenia: an update. Expert Review of Neurotherapeutics. 12: 801-12. PMID 22853788 DOI: 10.1586/ern.12.65  0.52
2012 McEwen AM, Burgess DT, Hanstock CC, Seres P, Khalili P, Newman SC, Baker GB, Mitchell ND, Khudabux-Der J, Allen PS, LeMelledo JM. Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2428-35. PMID 22805604 DOI: 10.1038/npp.2012.101  0.52
2012 Simpson SM, Hickey AJ, Baker GB, Reynolds JN, Beninger RJ. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats. Pharmacology, Biochemistry, and Behavior. 102: 109-17. PMID 22503968 DOI: 10.1016/j.pbb.2012.03.027  0.52
2012 Nunes E, Schneider B, Dursun S, Baker G, Hallak J. Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case report. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 34: 114-5. PMID 22392398  0.52
2012 Wei Z, Gabriel GG, Rui L, Cao X, Pennington PR, Chlan-Fourney J, Nazarali AJ, Baker GB, Mousseau DD. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex. Journal of Alzheimer's Disease : Jad. 28: 403-22. PMID 22045496 DOI: 10.3233/JAD-2011-111241  0.52
2011 Burback L, Baker GB, Dursun SM. Annual high-dose vitamin D supplementation does not affect mental well-being in older women. Evidence-Based Mental Health. 14: 103. PMID 22009237 DOI: 10.1136/ebmh.2011.100139  0.52
2011 Oliveira JP, Lobão B, Machado-de-Sousa JP, Baker GB, Dursun S, Hallak JE. Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 33: 223-4. PMID 21971773 DOI: 10.1590/S1516-44462011000300003  0.52
2011 Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH, Steinman L, Baker GB, Power C. Impaired neurosteroid synthesis in multiple sclerosis. Brain : a Journal of Neurology. 134: 2703-21. PMID 21908875 DOI: 10.1093/brain/awr200  0.52
2011 Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain, Behavior, and Immunity. 25: 1677-88. PMID 21723939 DOI: 10.1016/j.bbi.2011.06.011  0.52
2011 Musgrave T, Tenorio G, Rauw G, Baker GB, Kerr BJ. Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE). Neurochemistry International. 59: 28-38. PMID 21672584 DOI: 10.1016/j.neuint.2011.03.020  0.52
2011 Holt A, Mousseau DD, Baker GB. Special issue: amine oxidases: structures, mechanisms and therapeutic targets. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 977-8. PMID 21667272 DOI: 10.1007/s00702-011-0670-1  0.52
2011 Hallak JE, Dursun SM, Bosi DC, de Macedo LR, Machado-de-Sousa JP, Abrão J, Crippa JA, McGuire P, Krystal JH, Baker GB, Zuardi AW. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 198-202. PMID 21062637 DOI: 10.1016/j.pnpbp.2010.11.002  0.52
2010 Al-Nuaimi S, Chaves C, Hallak JE, Baker GB, Dursun S. New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 32: 333-8. PMID 21308251 DOI: 10.1590/S1516-44462010000400003  0.52
2010 Allman AA, Benkelfat C, Durand F, Sibon I, Dagher A, Leyton M, Baker GB, O'Driscoll GA. Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology. 211: 423-33. PMID 20602089 DOI: 10.1007/s00213-010-1912-x  0.52
2010 Rauw GA, Grant SL, Labrie V, Roder JC, Antflick JE, Hampson DR, Baker GB. Determination of L-serine-O-phosphate in rat and mouse brain tissue using high-performance liquid chromatography and fluorimetric detection. Analytical Biochemistry. 405: 260-2. PMID 20599655 DOI: 10.1016/j.ab.2010.06.024  0.52
2010 Song MS, Baker GB, Dursun SM, Todd KG. The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. Journal of Neurochemistry. 114: 1405-13. PMID 20557421 DOI: 10.1111/j.1471-4159.2010.06857.x  0.52
2010 Huxtable AG, Zwicker JD, Alvares TS, Ruangkittisakul A, Fang X, Hahn LB, Posse de Chaves E, Baker GB, Ballanyi K, Funk GD. Glia contribute to the purinergic modulation of inspiratory rhythm-generating networks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 3947-58. PMID 20237265 DOI: 10.1523/JNEUROSCI.6027-09.2010  0.52
2010 Chaves C, de Marque CR, Wichert-Ana L, Maia-de-Oliveira JP, Itikawa EN, Crippa JA, Zuardi AW, Todd KG, Baker GB, Dursun SM, Hallak JE. Functional neuroimaging of minocycline's effect in a patient with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 550-2. PMID 20138948 DOI: 10.1016/j.pnpbp.2010.01.020  0.52
2010 Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, Dickie P, Baker G, Hollenberg MD, Cohen EA, Power C. MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1799-812. PMID 20097875 DOI: 10.1096/fj.09-147819  0.52
2010 Antflick JE, Baker GB, Hampson DR. The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice. Amino Acids. 39: 145-53. PMID 19921396 DOI: 10.1007/s00726-009-0387-8  0.52
2009 Antflick JE, Vetiska S, Baizer JS, Yao Y, Baker GB, Hampson DR. L-Serine-O-phosphate in the central nervous system. Brain Research. 1300: 1-13. PMID 19747453 DOI: 10.1016/j.brainres.2009.08.087  0.52
2009 Maingat F, Vivithanaporn P, Zhu Y, Taylor A, Baker G, Pearson K, Power C. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8429-37. PMID 19571133 DOI: 10.1523/JNEUROSCI.5818-08.2009  0.52
2009 Labrie V, Fukumura R, Rastogi A, Fick LJ, Wang W, Boutros PC, Kennedy JL, Semeralul MO, Lee FH, Baker GB, Belsham DD, Barger SW, Gondo Y, Wong AH, Roder JC. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics. 18: 3227-43. PMID 19483194 DOI: 10.1093/hmg/ddp261  0.52
2009 Krebs-Kraft DL, Rauw G, Baker GB, Parent MB. Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels. European Journal of Pharmacology. 611: 44-52. PMID 19345207 DOI: 10.1016/j.ejphar.2009.03.055  0.52
2009 Labrie V, Duffy S, Wang W, Barger SW, Baker GB, Roder JC. Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learning & Memory (Cold Spring Harbor, N.Y.). 16: 28-37. PMID 19117914 DOI: 10.1101/lm.1112209  0.52
2008 Todd KG, Baker GB. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 11: 14s-21s. PMID 19203467  0.52
2008 McDonald GR, Hudson AL, Dunn SM, You H, Baker GB, Whittal RM, Martin JW, Jha A, Edmondson DE, Holt A. Bioactive contaminants leach from disposable laboratory plasticware. Science (New York, N.Y.). 322: 917. PMID 18988846 DOI: 10.1126/science.1162395  0.52
2008 MacKenzie EM, Fassihi A, Davood A, Chen QH, Rauw G, Rauw G, Knaus EE, Baker GB. N-Propynyl analogs of beta-phenylethylidenehydrazines: synthesis and evaluation of effects on glycine, GABA, and monoamine oxidase. Bioorganic & Medicinal Chemistry. 16: 8254-63. PMID 18693021 DOI: 10.1016/j.bmc.2008.07.027  0.52
2008 Urichuk L, Prior TI, Dursun S, Baker G. Metabolism of atypical antipsychotics: Involvement of cytochrome P450 enzymes and relevance for drug-drug interactions Current Drug Metabolism. 9: 410-418. PMID 18537577 DOI: 10.2174/138920008784746373  0.52
2008 Natesan S, Reckless GE, Barlow KBL, Odontiadis J, Nobrega JN, Baker GB, George SR, Mamo D, Kapur S. The antipsychotic potential of l-stepholidine - A naturally occurring dopamine receptor D1 agonist and D2 antagonist Psychopharmacology. 199: 275-289. PMID 18521575 DOI: 10.1007/s00213-008-1172-1  0.52
2008 Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S, Booij L, Baker G, Soucy JP, Zimmer L, Descarries L. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biological Psychiatry. 63: 1135-40. PMID 18191817 DOI: 10.1016/j.biopsych.2007.11.016  0.52
2008 Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, Baker G, Allen P, Tibbo P, Hui E, Le Melledo JM. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biological Psychiatry. 63: 1178-84. PMID 18061146 DOI: 10.1016/j.biopsych.2007.10.007  0.52
2008 MacKenzie EM, Grant SL, Baker GB, Wood PL. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition Neurochemical Research. 33: 430-436. PMID 17768678 DOI: 10.1007/s11064-007-9448-0  0.52
2008 Ahboucha S, Pomier-Layrargues G, Vincent C, Hassoun Z, Tamaz R, Baker G, Butterworth RF. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Neurochemistry International. 52: 569-74. PMID 17669554 DOI: 10.1016/j.neuint.2007.06.002  0.52
2007 Baker GB, Sowa B, Todd KG. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? Journal of Psychiatry & Neuroscience : Jpn. 32: 313-5. PMID 17823646  0.52
2007 Schimanski LA, Ali DW, Baker GB, Nguyen PV. Impaired hippocampal LTP in inbred mouse strains can be rescued by beta-adrenergic receptor activation. The European Journal of Neuroscience. 25: 1589-98. PMID 17425584 DOI: 10.1111/j.1460-9568.2007.05376.x  0.52
2007 Leyton M, aan het Rot M, Booij L, Baker GB, Young SN, Benkelfat C. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. Journal of Psychiatry & Neuroscience : Jpn. 32: 129-36. PMID 17353942  0.52
2007 MacKenzie EM, Odontiadis J, Le Mellédo JM, Prior TI, Baker GB. The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders Cellular and Molecular Neurobiology. 27: 541-574. PMID 17235696 DOI: 10.1007/s10571-006-9086-0  0.52
2007 Odontiadis J, MacKenzie EM, Natesan S, Mamo D, Kapur S, Baker GB. Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 850: 544-547. PMID 17161981 DOI: 10.1016/j.jchromb.2006.11.039  0.52
2007 Rittenbach KA, Holt A, Ling L, Shan J, Baker GB. Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes. Cellular and Molecular Neurobiology. 27: 179-90. PMID 17160483 DOI: 10.1007/s10571-006-9085-1  0.52
2006 Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Archives of General Psychiatry. 63: 1386-95. PMID 17146013 DOI: 10.1001/archpsyc.63.12.1386  0.52
2006 Wood PL, Khan MA, Moskal JR, Todd KG, Tanay VA, Baker G. Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Research. 1122: 184-90. PMID 17026969 DOI: 10.1016/j.brainres.2006.09.003  0.52
2006 Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB. Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 844: 278-82. PMID 16890503 DOI: 10.1016/j.jchromb.2006.07.022  0.52
2006 Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis British Medical Journal. 332: 385-388. PMID 16473858 DOI: 10.1136/bmj.38731.532766.F6  0.52
2005 Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S. The efficacy and safety of exogenous melatonin for primary sleep disorders: A meta-analysis Journal of General Internal Medicine. 20: 1151-1158. PMID 16423108 DOI: 10.1111/j.1525-1497.2005.0243.x  0.52
2005 Jindal R, MacKenzie EM, Baker GB, Yeragani VK. Cardiac risk and schizophrenia Journal of Psychiatry and Neuroscience. 30: 393-395. PMID 16327872  0.52
2005 Rittenbach K, Sloley BD, Ling L, Coutts RT, Shan J, Baker GB. A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent Journal of Pharmacological and Toxicological Methods. 52: 373-378. PMID 16087356 DOI: 10.1016/j.vascn.2005.07.001  0.52
2005 Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides. 26: 1394-400. PMID 16042979 DOI: 10.1016/j.peptides.2005.03.029  0.52
2005 Sowa B, Rauw G, Davood A, Fassihi A, Knaus EE, Baker GB. Design and biological evaluation of phenyl-substituted analogs of beta-phenylethylidenehydrazine. Bioorganic & Medicinal Chemistry. 13: 4389-95. PMID 15927473 DOI: 10.1016/j.bmc.2005.04.072  0.52
2004 Le Mellédo JM, Baker GB. Role of progesterone and other neuroactive steroids in anxiety disorders Expert Review of Neurotherapeutics. 4: 851-860. PMID 15853511 DOI: 10.1586/14737175.4.5.851  0.52
2004 Le Mellédo JM, Mahil N, Baker GB. Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry and Neuroscience. 29: 414-416. PMID 15644982  0.52
2004 Sowa BN, Holt A, Todd KG, Baker GB. Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian Journal of Experimental Biology. 42: 851-7. PMID 15462176  0.52
2004 Holt A, Wieland B, Baker GB. Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. British Journal of Pharmacology. 143: 495-507. PMID 15451775 DOI: 10.1038/sj.bjp.0705986  0.52
2004 Salsali M, Holt A, Baker GB. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cellular and Molecular Neurobiology. 24: 63-76. PMID 15049511 DOI: 10.1023/B:CEMN.0000012725.31108.4a  0.52
2004 Fletcher PJ, Sinyard J, Salsali M, Baker GB. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology. 174: 406-13. PMID 14740149 DOI: 10.1007/s00213-003-1747-9  0.52
Show low-probability matches.